Infinity Pharmaceuticals, Inc.

Allied Machine & Engineering Corporation

Infinity Discovery, Inc.

James R Porter

Julian Adams

James I Wright

Louis Grenier

Roger H Pak

Yun Gao

Asimina T Georges Evangelinos

Alfredo C Castro

Martin R Tremblay

Michael Andrew Foley

Marta Nevalainen

Edward Holson

Brian C Austad

Somarajan Nair Janardanan Nair

David A Lutz

Chad M Lynch

John J Lee

Somarajannair Janardanannair

Sonali Puri

Michael A Foley

James L Wright

A drilling head for a tubular shank having an inside diameter and threads may comprise an axial body comprising a duct exiting through a first end; threads adjacent the first end corresponding to the threads on the shank and aligning the duct with the shank inside diameter; a bore from an outer surface of the body to the duct; and two axially extending approximately parallel and offset surfaces adjacent a second end; and an insert affixed between the offset surfaces, the insert comprising: a first face at least partially contacting one offset surface and a second face at least partially contacting the other offset surface; one or more cutting edges adjacent the first face, the second face, or both; and a cutting lip adjacent one or more cutting edges.

Ejector drill system

Aspects of the present invention provide compositions comprising a sulfur containing compound and a compound of the formula (I); and also provide methods of their preparation and use. 

Ansamycin hydroquinone compositions

The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.

Analogs of benzoquinone-containing ansamycins and methods of use thereof

Provided herein, inter alia, are solid forms of geldanamycin analogs, pharmaceutical compositions comprising a geldanamycin analog and a crystallization inhibitor, methods of making and using such compositions. Additionally, provided are methods for the treatment of cancer, a neoplastic disease state and/or a hyperproliferative disorder, and methods of inhibiting Heat Shock Protein 90 ('Hsp90').

Ansamycin formulations and methods of use thereof

Amorphous, polymorphic, and solvated forms of 17-amino geldanamycin are disclosed. These compounds are particularly useful for the treatment of cancer, a neoplastic disease state and/or a hyperproliferative disorder, and inhibiting Heat Shock Protein 90 ('Hsp90').

The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.

Cyclopamine analogues and methods of use thereof

Growing community of inventors

Rowley, MA, United States of America

James R Porter